| Literature DB >> 29376268 |
Chun-Xiao Wu1,2, Jing-Chun Zhang1,2, Yue Liu1,2, Lin-Qin Ma1,2, Yu Qiao1,2, Shu-Yan Lei1,2, Qiao-Xian Zheng1,2.
Abstract
This study aims to explore the intervention effect of Chinese medicine of nourishing kidney and clearing liver on intermittent hypoxia(IH) induced injury model of HUVECs through p38MAPK/NF-κB signaling pathway in vitro. HUVECs injury model was induced by modified IH treatment. The effective components of Chinese medicine of nourishing kidney and clearing liver including isochteroside, aucubin and ligustrazine were used as intervention drugs. The optimal compatibility concentration of them was screened in vitro, and then the optimal compatibility concentration was selected as the intervention dose to observe the effect on p38MAPK/NF-κB signaling pathway in IH induced injury model of HUVECs. The results showed that isochnae, aucubin and ligustrazine had the best anti-inflammatory effect at concentration of 0.01 mg•L-1. NF-κB p65 and p-IκB in the nucleus in IH group were significantly higher than those in the normal control(N) group and the other groups. Immunofluorescence staining showed significant translocation of NF-κB p65 nucleus in IH group, and HUVECs adhesion capacity in IH group was increased significantly. As compared with IH group, the expression levels of p-p38MAPK, NF-κB p65 and p-IκB in p38MAPK inhibitor(INH) group and Chinese medicine of nourishing kidney and clearing liver(GDC) group were significantly decreased, and HUVECs adhesion capacity in INH group and GDC group was significantly inhibited as well. The optimal concentration of Chinese medicine of nourishing kidney and clearing liver can inhibit the phosphorylation of p38MAPK, and then inhibit the nuclear translocation and transcription function of NF-κB. This may be the mechanism of the protective effect of Chinese medicine on IH induced injury model of HUVECs. Copyright© by the Chinese Pharmaceutical Association.Entities:
Keywords: Chinese medicine ; HUVECs ; NF-κB ; intermittent hypoxia ; p38MAPK
Mesh:
Substances:
Year: 2017 PMID: 29376268 DOI: 10.19540/j.cnki.cjcmm.20170928.001
Source DB: PubMed Journal: Zhongguo Zhong Yao Za Zhi ISSN: 1001-5302